WallStreetZenWallStreetZen

NYSE: RMD
Resmed Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Resmed earnings were $1.6B for the trailing 12 months ending Sep 30, 2026, with 12.2% growth year over year. The latest RMD earnings report on Sep 30, 2026 announced Q3 2026 earnings of $418.4M, up 9.1% from last quarter. For the last reported fiscal year 2026 ending Jun 30, 2026, RMD reported annual earnings of $1.5B, with 8.8% growth.

RMD past earnings growth

How has RMD's earnings growth performed historically?

Company
12.23%
Industry
35.26%
Market
91.66%
RMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
RMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
RMD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

RMD earnings history

Current Revenue
$5.7B
Current Earnings
$1.6B
Current Profit Margin
27.8%
RMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

RMD Return on Equity

Current Company
25.1%
Current Industry
13.3%
Current Market
35.3%
RMD's Return on Equity (25.1%)... subscribe to Premium to read more.
High Return on Equity Performance

RMD Return on Assets

Current Company
18.5%
Current Industry
10.3%
RMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RMD announces earnings.

RMD Return on Capital Employed

Current Company
29.41%
Current Industry
16.2%
RMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RMD vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RMD$2.26B$1.59B+26.12%$11.01
ALC$2.74B$643.00M+28.77%$1.31
WST$999.50M$638.90M+1.64%$8.97
MDLN$2.46B$566.00MN/AN/A
BAX$913.00M-$723.00MN/A-$1.42
View Top Medical Stocks

Resmed Earnings Reports & History FAQ

What were Resmed's earnings last quarter?

On RMD's earnings call on Oct 29, 2026, Resmed (NYSE: RMD) reported Q3 2026 earnings per share (EPS) of $2.93, up 23.11% year over year. Total RMD earnings for the quarter were $418.41 million. In the same quarter last year, Resmed's earnings per share (EPS) was $2.38.

If you're new to stock investing, here's how to buy Resmed stock.

Is Resmed profitable or losing money?

As of the last Resmed earnings report, Resmed is currently profitable. Resmed's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $1.59 billion, a 10.8% increase year over year.

What was RMD's earnings growth in the past year?

As of Resmed's earnings date in Oct 29, 2026, Resmed's earnings has grown 12.23% year over year. This is 23.03 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 35.26%. RMD earnings in the past year totalled $1.59 billion.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.